Shares of Bicara Therapeutics (BCAX.O) surged nearly 46% in their debut on Friday, giving the TPG-backed cancer therapy developer a market value of $1.29 billion in a sign of strong investor interest. Two other drug developers, Zenas BioPharma (ZBIO.O) and MBX Biosciences (MBX.O), also had smooth debuts on Friday, bolstering confidence for the biotech sector, which has seen some recent market entrants struggle.
Read the full article: TPG-Backed Bicara Therapeutics Shares Surge 46% in Stellar Market Debut //
Source: https://www.reuters.com/markets/deals/tpg-backed-bicara-therapeutics-shares-surge-46-stellar-market-debut-2024-09-13/